All terms in BMONT

Label Id Description
frequency PATO_0000044 [A physical quality which inheres in a bearer by virtue of the number of the bearer's repetitive actions in a particular time.]
amyloid-beta polypeptide 40 CHEBI_64646 [A beta-amyloid that is a 40 amino acid polypeptide of sequence Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu Met Val Gly Gly Val Val.]
amyloid-beta CHEBI_64645 [A peptide of 36-43 amino acids that is processed from the amyloid precursor protein. Appears to be the main constituent of amyloid plaques (deposits found in the brains of Alzheimer's disease patients).]
amyloid-beta polypeptide 42 CHEBI_64647 [A beta-amyloid that ia a 42 amino acid polypeptide of sequence Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu Met Val Gly Gly Val Val Ile Ala.]
Positive Predictive Value of Diagnostic Test NCIT_C41389 [The probability that an individual is affected with the condition when a positive test result is observed. Predictive values should only be calculated from cohort studies or studies that legitimately reflect the number of people in the population who have the condition of interest at that time since predictive values are inherently dependent upon the prevalence. PPVDT can be determined by calculating: number of true positive results divided by the sum of true positive results plus number of false positive results.]
uric acid CHEBI_27226 [An oxopurine that is the final oxidation product of purine metabolism.]
Negative Predictive Value of Diagnostic Test NCIT_C41390 [The probability that an individual is not affected with the condition when a negative test result is observed. This measure of accuracy should only be used if the data on the prevalence of condition of interest in given population is available. NPVDT can be determined by calculating: number of true negative results divided by the sum of true negative results plus number of false negative results.]
p-value OBI_0000175 [A quantitative confidence value that represents the probability of obtaining a result at least as extreme as that actually obtained, assuming that the actual value was the result of chance alone.]
Lipid Peroxidation OMIT_0016017 [Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor.]
Biochemical Processes OMIT_0026291 [Adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake (NUTRITIONAL SUPPORT).]
Cancer Research NCIT_C16199 [Systematic investigation into the causes of cancer and development of strategies for prevention, diagnosis, treatment, and cure.]
vitamin D deficiency EFO_0003762 [A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406)]
somatic genotype EFO_0004972 [The total sum of the genetic information of an organism's somatic cells]
germline genotype EFO_0004973 [The total sum of the genetic information of an organism's germline]
ARG1 OMIT_0030323
Spearman Correlation Test NCIT_C53249
myocardial infarction DOID_5844 [A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.]
Growth Disorders OMIT_0007313 [Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.]
investigation OBI_0000066 [a planned process that consists of parts: planning, study design execution, documentation and which produce conclusion(s).]
imaging assay OBI_0000185 [An assay that produces a picture of an entity.]